Whether about a comet hitting the Earth or a virus infecting the world, fear-based messages often do not succeed at changing people’s behaviors.
Using fever reducers or drinking too much fluid while battling the flu may upset the body’s delicate balancing act.
Sam Edwards/OJO Images via Getty Images
Our brains cannot easily understand tiny risks so we tend to overestimate them. That’s when we need a little extra help to make the best decisions about our health.
Little work has been done to understand young people’s willingness to receive COVID-19 vaccines. Above: a COVID-19 vaccination clinic at the University of Toronto Mississauga campus on May 6.
THE CANADIAN PRESS/ Tijana Martin
As vaccine eligibility is expanded to adolescents and young adults, understanding who might be more likely to be vaccine hesitant, and why, can help inform public health strategies
The pause on the Johnson & Johnson vaccine was lifted on April 23, 2021.
SOPA Images/Light Rocket via Getty Images
The CDC first paused, then unpaused, the administration of the Johnson & Johnson COVID-19 vaccine due to concerns about blood clots. But what are those clots, and how do they form?
If one adenoviral vaccine is linked with blood clots, it doesn’t mean all vaccines in this family will have that same effect. But it’s definitely worth health authorities assessing the data.
Vials of the Johnson & Johnson vaccine to prevent COVID-19. The use of this particular vaccine has been halted temporarily.
Justin Tallis/AFP via Getty Images
The one-dose vaccine developed by Johnson & Johnson is temporarily halted because of potentially serious blood clots seen in six women. An immunologist explains what this means for you.
We already track potential vaccine side-effects in Australia. So we’ll be using, and building on, years of experience in monitoring any long-term effects of COVID-19 vaccines.
Tamara Dus, director of University Health Network Safety Services, administers a Pfizer-BioNTech COVID-19 vaccine in Toronto.
THE CANADIAN PRESS/Frank Gunn
The arrival of COVID-19 vaccines has raised hope for an end to the pandemic. Hopefully that’s true, but there are variables. Here are some factors that could affect the success of the vaccine rollout.
Health workers are preparing COVID-19 vaccine Sinovac during first stage vaccination in Health Center, South Tagerang City, Indonesia, Januari 15, 2021. More than 8.000 health workers there are vacinnated.
ANTARA FOTO/Fauzan/foc
By prioritising vaccination for the elderly, Indonesia may optimally reduce the hospital burden and COVID-19 deaths amid a limited vaccine supply during the first vaccination phase.
Pharmacist Jessica Sahni prepares a Pfizer COVID-19 vaccine in New York City.
Bryan R. Smith/AFP via Getty Images
Lana Dbeibo, Indiana University School of Medicine
Now that two COVID vaccines have been authorized by the FDA, questions arise. Today, a physician from Indiana University School of Medicine answers five reader questions.
Sandra Lindsay, left, a nurse at Long Island Jewish Medical Center, is inoculated with the COVID-19 vaccine by Dr. Michelle Chester.
Mark Lennihan/Pool via Getty Images
A serious allergic reaction was reported in a health care worker in Alaska after she received the COVID-19 vaccine. Does this mean that people with allergies need to be concerned? An expert answers.
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford